Literature DB >> 29755781

Prolonged survival of metastatic hepatocellular carcinoma: a case report.

Nadiah Zainal1, Harissa Husainy Hasbullah2.   

Abstract

Management of hepatocellular carcinoma (HCC) generally follows EASL-EORTC clinical practise guideline. We report a case of a 50-year-old man who had multinodular HCC with lung metastases, whose management had deviated from the standard guideline but still survive 5 years after initial diagnosis.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); lung metastases; surgery

Year:  2018        PMID： 29755781      PMCID： PMC5934152          DOI： 10.21037/jgo.2018.01.04

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  13 in total

1.  Liver resection for hepatocellular carcinoma ≥5 cm.

Authors:  Giuseppe Maria Ettorre; Giovanni Battista Levi Sandri; Marco Colasanti; Gianluca Mascianà; Edoardo de Werra; Roberto Santoro; Pasquale Lepiane; Marzia Montalbano; Mario Antonini; Giovanni Vennarecci
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-24

2.  Clinical features of hepatocellular carcinoma with extrahepatic metastases.

Authors:  Mitsuteru Natsuizaka; Takumi Omura; Toru Akaike; Yasuaki Kuwata; Katsu Yamazaki; Takahiro Sato; Yoshiyasu Karino; Jouji Toyota; Toshihiro Suga; Masahiro Asaka
Journal:  J Gastroenterol Hepatol       Date:  2005-11       Impact factor: 4.029

3.  The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Yo Sasaki; Terumasa Yamada; Hidetoshi Eguchi; Koji Takami; Hiroaki Ohigashi; Masahiko Higashiyama; Osamu Ishikawa; Ken Kodama; Shingi Imaoka
Journal:  Am J Surg       Date:  2006-07       Impact factor: 2.565

4.  Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Authors:  Jian-hong Zhong; Yang Ke; Wen-feng Gong; Bang-de Xiang; Liang Ma; Xin-ping Ye; Tao Peng; Gui-sheng Xie; Le-qun Li
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

5.  A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.

Authors:  Guido Torzilli; Jacques Belghiti; Norihiro Kokudo; Tadatoshi Takayama; Lorenzo Capussotti; Gennaro Nuzzo; Jean-Nicolas Vauthey; Michael A Choti; Eduardo De Santibanes; Matteo Donadon; Emanuela Morenghi; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

6.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

7.  Liver resection improves the survival of patients with multiple hepatocellular carcinomas.

Authors:  Ming-Chih Ho; Guan-Tarn Huang; Yuk-Ming Tsang; Po-Huang Lee; Ding-Shinn Chen; Jin-Chuan Sheu; Chien-Hung Chen
Journal:  Ann Surg Oncol       Date:  2009-01-22       Impact factor: 5.344

8.  Long-term outcome after liver resection for hepatocellular carcinoma larger than 10 cm.

Authors:  Pierre Allemann; Nicolas Demartines; Hanifah Bouzourene; Adrien Tempia; Nermin Halkic
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

9.  Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.

Authors:  Shimul A Shah; Sean P Cleary; Alice C Wei; Ilun Yang; Bryce R Taylor; Alan W Hemming; Bernard Langer; David R Grant; Paul D Greig; Steven Gallinger
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

10.  Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.

Authors:  T F Greten; F Papendorf; J S Bleck; T Kirchhoff; T Wohlberedt; S Kubicka; J Klempnauer; M Galanski; M P Manns
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.